The quick reaction surface-to-air-missile missile developed by DRDO was test launched from the Integrated Test Range at Chandipur near here at about 3.08 pm from a vertical launcher against an electronic target at a very low altitude.
The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron.
The ministry of civil aviation on Wednesday said only two per cent of the passengers coming from countries that are not in the 'at-risk' list will be subject to random sampling for coronavirus and such passengers will be permitted to leave the airport after giving the samples.
Bibhu Prasad Routray explains why the US is supporting Japan's resolve to release 'treated' radioactive waste water into the Pacific Ocean. And what role China plays in the US decision.
The three students, two of them aged 20 and one 21, were also remanded in 14-day judicial custody by an Agra court, the officials said.
'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
There are 2,89,240 active cases of coronavirus infections in the country which comprises 2.86 per cent of the total caseload.
Join infectious disease specialist Dr Trupti Gilada on Rediff Chat and have all your queries on coronavirus answered.
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
How do you decide if you should take up a new job in these difficult times? HR guru Mayank Rautela has some tips that could help you decide.
'We need to prove to the world that quality vaccines and R&D are possible in India.'
As the national transporter is planning to come out with semi-high speed routes where trains can clock an average speed of 160-200 kmph, dedicated testing becomes essential.
"The allegations may be right or maybe wrong. He may say he did not say any such thing... It needs to be looked into," said the judge.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.
'Expectations do not intimidate me. In fact, they strengthen me.'
Burned by the shooting down of a MiG-21 aircraft and the capture of its pilot after a dogfight over the India-Pakistan border in February 2019, CATS eliminates the need to send pilots into enemy air space.
Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.
Prime Minister Narendra Modi had hoisted the national flag and addressed the nation from the ramparts of the Red Fort. He said that it was an occasion to remember freedom fighters who laid down their lives for the freedom of the country.
In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.
Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.
There are 12 sites across India, including private and public hospitals, conducting Phase 1 and 2 human clinical trials for Bharat Biotech's Covaxin. Based on an earlier letter by the Indian Council of Medical Research (ICMR) to the 12 sites, volunteer recruitments for the clinical trials were to begin by July 7. At least three sites are yet to kick-start the process.
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.
Once touted as a 'wonder drug', HCQ has been battling global controversies around its safety and efficacy as a prophylactic against the new coronavirus SARS-CoV-2.
A staff nurse from a Bihar hospital begs the prime minister for her life as the state's medical staff continues to treat suspected COVID-19 patients without protective safety kits.
The phase 3 clinical trial will cover around 28,500 subjects, aged 18 years and above, and it will be conducted in 21 sites across ten states, including Delhi, Mumbai, Patna and Lucknow.
Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.
The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.
Indians are more vulnerable to technology support-related scams compared to the global average, and lost over Rs 15,000 on average in such scam, a Microsoft research has found. According to the 2021 Global Tech Support Scam Research report, which looks at tech support scams and their impact, consumers in India experienced a relatively high scam encounter rate of 69 per cent during the past 12 months, close to the 70 per cent rate experienced in 2018. In contrast, there was an overall five-point drop in scam encounters globally with a rate of 59 per cent over the same period. The survey was conducted in Spring 2021 and asked consumers to share their experiences with tech support scams for the year prior (January 2020 to present).
The recent report in the New York Times that China had brought India's financial capital - Mumbai - to a halt by hacking the electricity supply grid has not come as a surprise to the CTOs (chief technology officers) and cyber security experts. Indian companies, including critical infrastructure providers such as power grids, ports and radar systems, lack the IT infrastructure to prevent hacking from hostile state actors like China and North Korea, warn security experts. Recently, the United States government warned of yet another breach of critical systems tied to Microsoft Exchange email systems that the company has blamed on China. The breach has impacted thousands of organisations in the US and its impact on India is still unknown.
Of the 23.9 million vaccinators who provide vaccination under the universal immunisation programme, 15.4 million will be used for Covid vaccination.
The Budget outlay for health and well being is Rs 2.23 lakh crore in 2021-22 as against BE of Rs 94,452 crore and marks an increase of 137 per cent," she said while presenting 2021-22 Budget in the Lok Sabha.
The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.
"After 20 years of war in Afghanistan, I refused to send another generation of America's sons and daughters to fight a war that should have ended long ago," US President Joe Biden.
HR Guru Mayank Rautela offers practical advice.
Evidence indicates that restoration of functioning of the education system as it was in pre-Covid times, as early as possible appears prudent in the current Indian context, they said.
Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.
The luxury car maker plans to recruit 1,000 people next year; in five years, research staff had jumped from 700 to 3,500.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances